From the Department of Surgical Science, Medical School, "Tor Vergata" University.
Academy of International Regenerative Medicine and Surgery Societies.
Plast Reconstr Surg. 2023 Jul 1;152(1):72e-82e. doi: 10.1097/PRS.0000000000010150. Epub 2023 Jan 2.
An increasing interest in maintaining a youthful appearance has led to the development of innovative and noninvasive aesthetic procedures for the treatment of facial aging, such as the recent use of autologous platelet-rich plasma (PRP). This article aims to review the literature and critically appraise the available evidence regarding the efficacy of autologous activated PRP and/or nonactivated PRP injection used for facial rejuvenation.
A systematic review regarding the clinical use of autologous activated PRP and autologous nonactivated PRP injection in facial rejuvenation against signs of aging was performed using the PubMed, MEDLINE, Embase, PreMEDLINE, Ebase, CINAHL, PsycINFO, Clinicaltrials.gov , Scopus, and Cochrane databases. The protocol was developed following the Preferred Reporting for Items for Systematic Reviews-Protocols guidelines. The included studies had to match predetermined criteria according to the patients, intervention, comparator, outcomes, and study design approach.
Eleven of the 12 studies identified, including three randomized split-face trials, showed improved results despite differences in study design and outcome measures, many of which were subjective.
Further randomized controlled trials and related systematic reviews need to be performed, as evidence-based medicine studies of level I are required to confirm PRP injection efficacy in facial rejuvenation, to consolidate the promising results of the studies identified in this systematic review.
人们对面部年轻化的关注度不断提高,这促进了许多创新性的非侵入性美容程序的发展,例如最近使用的自体富血小板血浆(PRP)。本文旨在对相关文献进行综述,并批判性评估自体激活 PRP 和/或非激活 PRP 注射在面部年轻化中的疗效的现有证据。
使用 PubMed、MEDLINE、Embase、PreMEDLINE、Ebase、CINAHL、PsycINFO、Clinicaltrials.gov、Scopus 和 Cochrane 数据库,对自体激活 PRP 和自体非激活 PRP 注射在面部年轻化中的临床应用进行了系统评价,以评估其对衰老迹象的疗效。该方案是按照系统评价报告的首选项目(PRISMA)指南制定的。纳入的研究必须根据患者、干预措施、对照、结局和研究设计方法符合预定标准。
12 项研究中有 11 项,包括 3 项随机分面试验,尽管研究设计和结局测量存在差异,但都显示出了改善的结果,其中许多是主观的。
需要进一步进行随机对照试验和相关的系统评价,因为需要进行基于循证医学的 I 级研究来证实 PRP 注射在面部年轻化中的疗效,以巩固本系统评价中确定的研究的有前途的结果。